Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 22, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21

Reporting Person: Sands Earl (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$7.02	2026-03-08	Common Stock (10256)		Direct
Employee Stock Option (right to buy)	$9.36	2025-09-07	Common Stock (102563)		Direct

Footnotes

F1: The option vests as to 25% of the shares on February 1, 2017. The remainder of the shares will vest in 36 substantially equal monthly installments thereafter.

F2: The option vests as to 25% of the shares on July 1, 2016. The remainder of the shares will vest in 36 substantially equal monthly installments thereafter.